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Signaling via Mitogen-Activated
Protein Kinase Kinase (MEK1) Is Required
for Golgi Fragmentation during Mitosis
changes characteristic of mitotic cells (Moreno and
Nurse, 1990). To date, the best-characterized direct tar-
gets for p34cdc2 kinase are the nuclear lamins (Heald and
McKeon, 1990; Peter et al., 1990). Is Golgi breakdown
similar to lamin disassembly (i.e., does p34cdc2 directly
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La Jolla, California 92093-0347 phosphorylate Golgi-specific substrates or are other ki-
nases activated that are responsible for Golgi break-
down)?
We have developed an assay to monitor Golgi frag-Summary
mentation inpermeabilized normal rat kidney (NRK) cells
using extracts made from mitotic NRK cells. Under theWe have developed anassay using permeabilized cells
experimental conditions, Golgi membranes lost theirto monitor fragmentation of the Golgi complex that
perinuclear location and were found as punctate struc-occurs during mitosis. Golgi stacks, in permeabilized
tures dispersed throughout the cytoplasm. This changeinterphase normal rat kidney(NRK) cells, upon incuba-
in Golgi membrane organization was monitored by im-tion with mitotic extracts undergo extensive fragmen-
munofluorescence microscopy (IF) using Golgi-specifictation, and the fragmented Golgi membranes are dis-
antibodies. We show that mitotic cytosol depleted ofpersed throughout the cytoplasm. We find that the
p34cdc2 kinase retains Golgi fragmentation activity. Ofcontinued presence of p34cdc2, the mitosis initiation
significance is the finding that depletion of MEK1, butkinase, is not necessary for Golgi fragmentation. In-
not its downstream cytosolic targets ERK1 and ERK2,stead, fragmentation depends on cytosolic mitogen-
from mitotic extract inhibits Golgi fragmentation. Theactivated protein kinase kinase 1 (MEK1 or MAPKK1).
downstream target of MEK1, however, is an ERK locatedHowever, the known cytoplasmic substrates for MEK1,
in the permeabilized NRK cells. The identification ofERK1, and ERK2 are not required for this process.
MEK1 as a key cytosolic kinase involved in Golgi frag-Interestingly, we find a Golgi-associated ERK, which
mentation is described below.we propose as the likely target for MEK1 in Golgi frag-
mentation.
Results
Introduction
Golgi Fragmentation by Mitotic Extract
Eukaryotic cells undergo extensive changes in their in- in a Permeabilized Cell System
tracellular architecture and physiology upon entry into NRK cells grown on Pronectin F coated glass coverslips
mitosis. Some of the notable changes in mammalian were permeabilized with digitonin, a detergent that spe-
cells include condensation of DNA, fragmentation of the cifically binds to cholesterol (Eilenberg et al., 1989). This
nuclear envelope and Golgi complex, depolymerization treatment resulted in preferential permeabilization of the
of cytoplasmic microtubules, and a block in endocytic plasma membrane due to its proportionally higher cho-
and exocytic protein transport (for a review, see Warren, lesterol content while intracellular organelles remained
1993). In nondividing mammalian cells, the Golgi com- relatively intact. We routinely observed permeabilization
plex, comprised of stacks of cisternae, is anchored to of greater than 90% of the cells by this method. Perme-
the pericentriolar region through association with the abilized cells were washedwith buffer containing1M KCl
microtubule organizing center (Rogalski and Singer, to remove cytosolic and peripheral membrane proteins.
1984). When cells enter mitosis, Golgi stacks fragment The high salt wash is essential for Golgi fragmentation
into small vesicles, clusters of vesicles, and tubular ele- by mitotic extract. Subsequently, salt-washed perme-
ments (Lucocq et al., 1987). In postmitotic cells, these abilized cells were incubated with mitotic extract and
fragments reassemble to form a perinuclear Golgi com- an ATP-regenerating system at 328C for 1 hr. The extent
plex in each daughter cell (Lucocq et al., 1989). This of Golgi fragmentation was then determined by fixing
process of vesiculation followed by reassembly has and processing cells for immunofluorescence micros-
been proposed to ensure partitioning of Golgi mem- copy (IF) using an antibody to the Golgi-specific protein,
branes into daughter cells during cell division (Warren, Mannosidase II (Man II). Figure 1A (no extract) shows
1993). Our aim is to address the mechanisms by which the normal, ribbon-like perinuclear appearance of the
the organization of Golgi membranes is regulated during Golgi complex in salt-washed, permeabilizedcells. Incu-
the cell cycle. bation of such permeabilized cells with interphase ex-
Entry of cells into mitosis requires formation of an tract (at the same protein concentration as mitotic ex-
active complex between p34cdc2 kinase and cyclins at tract) did not significantly perturb the organization of
G2±M boundary (Nurse, 1990). While we have come a Golgi membranes. However, the Golgi complex ap-
long way in our understanding of the mechanisms by peared less ribbon-like and more pericentriolar in these
which the activity of p34cdc2 kinase is regulated, it is cells. In contrast, incubation of permeabilized cells with
still not clear how p34cdc2 kinase induces the profound mitotic extract caused extensive fragmentation of the
Golgi complex. Staining with a cis Golgi marker such
as giantin, and trans and trans Golgi network (TGN)³To whom correspondence should be addressed.
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Figure 2. Fragmentation of the Golgi Apparatus Is by a Protein
Kinase
(A and B) Permeabilized salt-washed cells were incubated with mi-
totic extract (A) or with mitotic extract preteated with staurosporine
(B). While incubation with mitotic extract induces Golgi fragmenta-
tion, pretreatment of mitotic extract with staurosporine inhibits Golgi
fragmentation activity, and the complex remains perinuclear. Bar
10 mm.
(C) Percentage of cells with fragmented Golgi, after incubation with
mitotic extract (M) or with mitotic extract pretreated with stauro-
sporine (M 1 S). Staurosporine inhibited Golgi fragmentation in 75%
of cells. About 25% of cells show Golgi fragmentation even in the
presence of mitotic extract treated with staurosporine.
markers, sialyltransferase and TGN-38, respectively, re-
vealed that these markers also appeared fragmented
under these conditions (data not shown). On analyzing
200 cells on duplicate coverslips, Golgi fragmentation
was observed in greater than 90% of the cells (Figure
1B).Golgi membranes did not fragment when permeabil-
ized cells were incubated with mitotic extract on ice
or when the cellular ATP pool was depleted (data not
Figure 1. Golgi Fragmentation in Permeabilized Cells by Mitotic Ex- shown). Thus, fragmentation of Golgi membranes by
tract mitotic extract is a temperature- and energy-dependent
(A) NRK cells grown on coverslips and incubated with 2 mM thymi- process.
dine for 8 hr at 378C were permeabilized by digitonin treatment and
subsequently washed with 1M KCl in KHM. Cells were incubated
Fragmentation of the Golgi Complex Iswith no extract (top panel), incubated with interphase extract (center
by a Kinase(s) Distinct from p34cdc2panel) or mitotic extract (bottom panel) and an ATP-regenerating
In order to determine if the Golgi breakdown process issystem at 328C for 1 hr. Cells were fixed and stained with anti Man
II antibody. Incubationof permeabilized cellswith noextract showsa mediated by a kinase(s), semiintact cells were incubated
perinuclear ribbon-like Golgi apparatus; incubation with interphase with mitotic extract that had been pretreated with stau-
extract perturbsthe ribbon-like Golgi organization; however, incuba- rosporine, a broad-range kinase inhibitor. As shown in
tion with mitotic extract causes extensive fragmentation of this or-
Figure 2A, mitotic extract in the absence of stauro-ganelle. Bar 10 mm.
sporine fragmented the Golgi, while in the presence of(B) Percentage of cells with fragmented Golgi, after incubation with
the inhibitor, the Golgi complex remained intact andinterphase extract (I) and mitoticextract (M). The change in organiza-
tion of Golgi membranes, from intact perinuclear Golgi to punctate perinuclear (Figure 2B). Counting of cells on duplicate
structures dispersed all over the cytoplasm, as shown above, is coverslips showed that Golgi breakdown was inhibited
the basis of quantitation. On duplicate coverslips, 200 cells were in about 75% of cells in the presence of staurosporine
counted. This criterion was maintained throughout the study to
(Figure 2C). About25% of cells showed Golgi fragmenta-score for Golgi fragmentation. Incubation of semiintact cells with
tion that was not inhibited by treating mitotic extractinterphase extract resulted in 3% of cells with fragmented Golgi,
with staurosporine, that is, 25% of the signal in ourassaywhile incubation with mitotic extract induced fragmentation in more
than 90% of cells. was kinase independent.
MEK1 in Golgi Fragmentation
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Figure 3. Depletion of p34cdc2 from Mitotic Cytosol Does Not Inhibit
Golgi Fragmentation
(A) Mitotic extract is depleted of p34cdc2 by p13 affinity chromatogra-
phy. The extent of p34cdc2 depletion is monitored by an immunoblot-
ting assay (top panel). Mitotic extract (D) is quantitatively depleted
of p34cdc2 by 75 min, and by 90 min there is no visible p34cdc2 present
in the extract. (M) represents mock depleted extract. The bottom
panel shows an immunoblot for a control protein, p97, which is not
depleted by this treatment.
(B) Percentage of cells with fragmented Golgi after incubation with
mitotic extract (M) or with p34cdc2 depleted extract (p13). Depleted
extract induces Golgi fragmentation in 70% of cells.
Figure 4. Separation of the Golgi Fragmenting Kinase from p34cdc2Having shown that a kinase(s) is involved in Golgi
by a Phosphocellulose (P11) Columnfragmentation, we then addressed whether p34cdc2 is
Mitotic extract is fractionated on a phosphocellulose (p11) column.directly involved in this process. Mitotic extract was
Flowthrough was collected and the column eluted with increasingselectively depleted of p34cdc2 by p13 affinity chromatog-
salt concentration. Each fraction was concentrated using a centri-raphy (Brizuela et al., 1987). The extent of affinity deple-
con 10 concentrator.
tion of p34cdc2 was monitored by immunoblotting and (A) Column fractions were immunoblotted with anti p34cdc2 antibody
assaying for phosphorylation of histone H1, which is a and assayed for H1 kinase activity. p34cdc2 peaks in fractions 5±6,
measure of p34cdc2 kinase activity. In Figure 3A (top and H1 kinase activity also peaks in the same fractions.
(B) Percentage of cells with fragmented Golgi upon incubation withpanel), p34cdc2 is absent from mitotic extract by 90 min
mitotic extract (M), a combination of flowthrough and eluate (FT 1of incubation with p13 beads; in contrast, a control pro-
E), flowthrough alone (FT), pool A (bound fractions 1±3), pool B (pooltein p97 remains undepleted under identical conditions
fractions 4±8, p34cdc2 containing pool), pool C (bound fractions 9±12),
(bottom panel). p34cdc2-depleted extract still retained the or flowthrough pretreated with the kinase inhibitor staurosporine
ability to fragment the Golgi in 70% of cells as seen (FT 1 S). When cells are incubated with FT 1 E, 75% of cells show
in Figure 3B. This activity was lost upon treatment of Golgi fragmentation, and 65% in the case of FT alone. Pools A, B,
or C do not show any significant fragmentation activity and FT 1 Sdepleted extract with staurosporine (data not shown).
inhibits Golgi fragmentation activity.These results show that once cells have entered mitosis
through activation of p34cdc2 kinase, extracts from such
cells can be depleted of p34cdc2 kinase without affecting A (bound fractions 1±3), pool B (fractions 4±8, p34cdc2-
Golgi fragmentation activity. containing pool), and pool C (fractions 9±12) did not
show any fragmentation activity individually or when
mixed with each other. No significant increase in frag-Separation of the Golgi Fragmenting
Kinase from p34cdc2 mentation activity of flowthrough was observed when it
was mixed with any of the eluate pools, A, B, or C (dataSince our results indicate that the continued presence
of p34cdc2 is not required for Golgi breakdown, we de- not shown). These results indicate that flowthrough con-
tains the necessary components for Golgi fragmenta-cided to fractionate mitotic extract to obtain a kinase(s)
activity that is separable from p34cdc2. Mitotic extract tion. When flowthrough was incubated with stauro-
sporine, Golgi fragmentation was inhibited, stronglywas fractionated on a phosphocellulose (p11) column.
Flowthrough from the column was collected and the implicating a kinase(s) in this process (Figure 4B).
column eluted with increasing salt concentration. Each
column fraction was assayed for H1 kinase activity and Identification of the Mitotic Kinase(s)
Involved in Golgi Fragmentationimmunoblotted with anti p34cdc2 antibody. As seen in
Figure 4A, p34cdc2 was found in fractions 4±8, with the We first sought to test whether the Golgi fragmenting
kinase can be categorized to a general class of kinases.highest amounts in fractions 5±6. H1 kinase activity, a
measure of p34cdc2 kinase activity, had the same distribu- In order to identify the class to which the Golgi disas-
sembly kinase(s) belongs, we have made use of varioustion. Each of these fractions or pools was tested for
Golgi breakdown activity (Figure 4B). Golgi fragmenta- specific inhibitors that have beendeveloped for different
kinases. Olomoucine is a specific inhibitor of cyclin-tion activity was observed in 70% of cells when
flowthrough and eluate from the column were mixed. dependent kinases, especially of cyclin A±dependent
kinases. Mitotic extract after preincubation with olo-When flowthrough (devoid of active p34cdc2) was used,
Golgi breakdown was observed in 65% of cells. Pool moucine was added to salt-washed, semiintact cells.
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the kinase(s) responsible for Golgi fragmentation does
not belong to PKA or PKC families.
Golgi Fragmenting Kinase in the Mitotic
Extract Is a MAP Kinase Kinase
Mitogen-activated protein kinases (MAPKs), also called
extracellular signal-regulated kinases (ERKs), are a fam-
ily of protein kinases that function in a wide variety of
intracellular signal transduction pathways (Ahn et al.,
1993; Marshall, 1994; Seger and Krebs, 1995). MAPK
activation requires concomitant phosphorylation on
specific Thr and Tyr residues by MAP kinase kinase
(MAPKK or MEK; Zheng and Guan, 1993). MEK, in turn,
is a substrate for phosphorylation by several kinases
such as Raf, Mos, and MEKK (Dent et al., 1992; Lange-
Carter et al., 1993; Posada et al., 1993). The four major
pathways leading to MAPK activation are the p44/p42,
the SEK-SAPK/JNK-c-Jun, the p38 (HOG), and BMK1/
ERK5 pathways. Each of these is activated by largely
distinct stimuli.
To test if a MAPK in the mitotic extract is involved in
Golgi fragmentation, the extract was preincubated with
different concentrations of PD098059 (PD), a highly spe-
cific inhibitor of MEK1 (Alessi et al., 1995; Dudley et al.,
1995). This noncompetitive inhibitor blocks activation of
MEK1 by Raf or MEKK. Treatment of mitotic extract with
increasing concentrations of PD resulted in increased
Figure 5. Effect of Protein Kinase Inhibitors on Golgi Fragmentation inhibition of Golgi fragmentation (Figure 5B). H1 kinase
by Mitotic Extract activity of mitotic extract with the inhibitor remained
(A) Percentage of cells with fragmented Golgi upon incubation of comparable to untreated mitotic extract, indicating that
mitotic extract with either no inhibitor (ME), with olomoucine (ME 1 p34cdc2 levels remained unaltered under these conditions
OLO), calphostin C (ME 1 CAL C), or PKI (ME 1 PKI). These kinase (data not shown). On theother hand, if cells were treated
inhibitors do not inhibit Golgi fragmentation.
with PD for 45 min at 378C followed by removal of the(B) Percentage of cells with fragmented Golgi upon incubation with
inhibitor, adding mitotic extract to such cells did notuntreated (0) or with mitotic extract treated with 25, 50, or 75 mM
inhibit fragmentation (data not shown). Therefore, inhibi-of PD. Treatment of mitotic extract with increasing concentrations
of PD results in a concomitant increase in inhibition of Golgi frag- tion of MEK1 in mitotic extract and not in semiintact
mentation. cells prevents Golgi fragmentation. Since PD did not
(C) Effect of PD on the activity of MEK1 in the mitotic extract. The inhibit the SAPK or p38-dependent cascades, our re-
activity of MEK1 is measured as the phosphorylation of MBP as a sults indicate involvement of p44/42 (ERK1 and ERK2)
consequence of ERK2 activation by MEK1 in the presence or ab-
kinases in Golgi fragmentation.sence of PD. Increasing concentrations of PD inhibit the activity of
To further demonstrate that PD inhibits the enzymaticMEK in the mitotic extract.
activity of MEK1 in mitotic extract, we carried out the
following experiment. A routine procedure to test the
Golgi fragmentation was monitored by staining with an activity of ERK1 and ERK2 (substrates of MEK1) was
antibody to Man II, and the ability of cytosol to phosphor- performed by monitoring specific phosphorylation of
ylate H1 was also measured. While olomoucine inhibited myelin basic protein (MBP) in an immune complex assay
H1 kinase activity, the Golgi complex remained intact (Boulton and Cobb, 1991). Mitotic extract was incubated
in greater than 80% of thecells (Figure 5A). These results with increasing concentration of PD, and this reaction
suggest that the Golgi fragmenting kinase is distinct mixture was used in parallel to monitor Golgi fragmenta-
from a cyclin-dependent kinase (especially cyclin A). tion and MEK activity. The effect of PD on MEK activity
Treatment of mitotic extract with calphostin C, a specific was monitored by the following scheme. PD-treated or
inhibitor of protein kinase C (PKC), had a moderate effect untreated mitotic extract was incubated with anti-MEK1
on Golgi fragmentation by the extract as shown in Figure antibody bound to protein G Sepharose. The immu-
5A. H1 kinase activity of calphostin C±treated mitotic noabsorbed MEK1 was incubated with unphosphory-
extract was similar to the noninhibitor-treated extract. lated ERK2 (bacterially expressed) for 30 min and 308C.
When mitotic extract was treated with PKI, a specific The beads were removed by centrifugation, and the
inhibitor of protein kinase A (PKA), fragmentation of the supernatant containing ERK2 was incubated with MBP,
Golgi was observed in 90% of cells. Although PKI had g-(32P) ATP for 30 min at 308C. The reaction was stopped
little effect on Golgi breakdown, it lowered H1 kinase by adding Laemmli buffer, analyzed by SDS-PAGE, and
activity of the mitotic extract as compared to the extract quantitated using a phosphorimager. The results of such
without the inhibitor. Both PKI and calphostin C inhibited an experiment are shown in Figure 5C. The extent of
activities of PKA and PKC, respectively, in other assays phosphorylation of MBP by ERK2 as a result of activa-
that were carried out to show that the inhibitors are tion by MEK1 from untreated mitotic extract was as-
sumed as 100%. At 25 mM PD, MEK1 was 78% active;functional (data not shown). These results indicate that
MEK1 in Golgi Fragmentation
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Figure 7. Cytosolic ERKs Are Not Required for Golgi Fragmentation
(A) Top panel shows a representative Western blot of mock (M) and
ERK2-depleted (D) mitotic extract. Almost complete depletion of
ERK2 is achieved in 3 hr. Bottom panel shows that under identical
Figure 6. MEK1 Depletion Inhibits Golgi Fragmentation
conditions a control protein, p97, is not depleted.
(A) Top panel shows an immunoblot of mock and MEK1-depleted (B) Percentage of cells with fragmented Golgi is not different in
mitotic extracts for a single experiment. Greater than 90% depletion ERK2-depleted mitotic extract as compared to mock extract. The
of MEK1 was achieved in 3 hr in this representative experiment. data shown is an average of three independent experiments.
The bottom panel shows that under identical conditions, a control
protein p97 was not depleted. The averageextent of MEK1 depletion
obtained by densitometric scanning of three separate blots was
MEK1 depletion inhibits Golgi fragmentation (Figure 6B).80%.
(B) Mock and MEK1-depleted extract are tested in the Golgi frag- To further ascertain that this loss in fragmentation is
mentation assay. The data shown is an average of three different due to MEK1 depletion, we added constitutively active
experiments. MEK1 depletion inhibits Golgi fragmentation (MEK MEK1 to depleted extract. As seen in Figure 6B, addition
dep). Adding back pure MEK1 (MEK dep 1 MEK) restores Golgi
of constitutive MEK1 restored fragmentation activity tofragmentation to that observed with mock depleted mitotic extract.
depleted extract. The data shown in Figure 6B is anThe last histogram (Mock 1 Stauro) shows that 25% of Golgi frag-
average of three independent experiments. Depletion ofmentation is not inhibited by treating mitotic extract with the generic
kinase inhibitor staurosporine (i.e., 25% Golgi fragmentation in our MEK1 resulted in inhibition of Golgi fragmentation in
assay was not kinase dependent). Thus, on depleting MEK1, inhibi- 74% of cells, taking into account the contribution by the
tion of Golgi fragmentation was in 74% of cells, taking into account kinase-independent background (shown by a hatched
the contribution by the kinase-independent background.
histogram in Figure 6B). The loss of Golgi fragmentation
upon depletion of MEK1 and its restoration upon addi-
tion of MEK1 is a convincing demonstration of the essen-at 50 mM, 38% active; and at 75 mM, 35% active. The
parallel experiment revealed that at 25 mM PD, Golgi tial role of MEK1 in Golgi breakdown.
fragmentation was observed in 75%; at 50 mM PD, in
35%; and at 75 mM PD, in 33% of cells. These results ERK1 and ERK2 in the Mitotic Extract Are
Not Required for Golgi Fragmentationdemonstrate that PD inhibits MEK1 activity in the mitotic
extract, and this correlates with inhibition of Golgi frag- The only known targets for MEK1 to date are ERK1 and
ERK2 (Seger et al., 1992). To test if ERK2 in the mitoticmentation.
extract is necessary for Golgi fragmentation, mitotic ex-
tract was depleted of ERK2 using an anti ERK2 antibodyDepletion of MEK 1 Prevents Golgi
Fragmentation by Mitotic Extract conjugated to protein G Sepharose. ERK2 was almost
completely depleted from mitotic extract after 3 hr ofHaving shown that PD inhibits the activity of MEK1 and
Golgi fragmentation by mitotic extract, we further tested incubation (Figure 7A, top panel). The bottom panel indi-
cates that a control protein, p97, was not depleted underthe requirement of MEK1 in the breakdown process. An
antibody recognizing the N-terminal domain of MEK1 identical conditions. The mock- and ERK2-depleted mi-
totic extract were tested in the Golgi breakdown assay.was conjugated to protein G Sepharose beads and em-
ployed for depleting MEK1 from mitotic extract. The top As shown in Figure 7B, depletion of ERK2 had no effect
on Golgi fragmentation. ERK1 activity was retained inpanel of Figure 6A is a Western blot of mock (M)± and
MEK1-depleted (D) extract for a single experiment while MEK1-inhibited mitotic extract, indicating that ERK1 in
the mitotic extract is not required either for Golgi frag-the bottom panel shows a control blot with anti p97
antibody. Greater than 90% depletion of MEK1 was mentation (data not shown). These results demonstrate
that the known cytoplasmic substrates of MEK1 (i.e.,achieved in 3 hr in this representative experiment. The
average extent of MEK1 depletion for three different ERK1 and ERK2) in the mitotic extract are not essential
for Golgi fragmentation.experiments was 80%. Depletion could not be carried
out beyond 3 hr because there was increasing loss of
fragmentation activity of mock-depleted extract due to Is the Downstream Target of MEK1 in Golgi
Fragmentation an ERK?nonspecific loss of essential components on protein
G Sepharose beads. The mock- and MEK1-depleted We have shown that ERK-depleted mitotic extract is
capable of fragmenting the Golgi. However, MEK-mitotic extracts, when tested in the assay, revealed that
Cell
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Do Golgi Membranes Contain an ERK?
To test the localization of ERK in semiintact cells, we
carried out immunofluorescence with a broadly reactive
ERK (rabbit) antibody. Permeabilized NRK cells were
washed with 1 M KCl, fixed and stained with a Golgi-
specific marker, Giantin, and the anti-ERK antibody. We
made use of Giantin (mouse antibody) as a Golgi marker,
instead of Man II (rabbit) for double staining of cells. The
anti-ERK antibody under these conditions recognized
cytoplasmic and nuclear staining predominantly with a
faint perinuclear staining. However, when such cells
were washedwith mild detergent (0.0025% Triton X-100)
in a cytoskeletal stabilization buffer, perinuclear staining
was prominent (Figure 8B). This staining completely co-
localized with the staining of Golgi-specific Giantin, indi-
cating that an ERK is tightly associated (resistant to 1
M KCl and up to 0.01% detergent) with Golgi mem-
branes. The ERK antibody showed additional nuclear
and cytoskeletal staining as expected.
To further demonstrate the presence of an ERK on
Golgi membranes, we carried out the following experi-
ment. NRK cells were treated with a microtubule depo-
lymerizing agent, nocodazole, for a short period of time.
This treatment resulted in dispersal of Golgi stacks from
the perinuclear region throughout the cytoplasm (Rogal-
ski and Singer, 1984). Nocodazole-treated cells were
washed to remove the drug, permeabilized, and washed
with salt and mild detergent. The cells were fixed and
processed for IF microscopy using anti-ERK and Giantin
antibodies. As seen in Figure 9B, there was completeFigure 8. The Downstream Target of MEK1 Is an ERK in the Perme-
colocalization of staining obtained by these antibodies.abilized NRK Cells
In addition in the case of ERK antibody, nuclear and(A) Preincubation of semiintact, salt-washed cells with exogenously
cytoskeletal staining was observed. These results showadded increasing concentrations of inactivated ERK2 but not acti-
vated ERK2 inhibits Golgi fragmentation by mitotic extract. that dispersed Golgi stacks retain the associated ERK.
(B) Colocalization of the Golgi marker Giantin with an ERK, in semiin- We then addressed whether nonperinuclear stacks,
tact, salt-washed, detergent-extracted cells. Cells are stained with which contain ERK, undergo fragmentation with mi-
an anti-Giantin antibody (left panel) and with a broadly reactive anti-
totic extract. Nocodazole-treated, permeabilized, salt-ERK antibody (right panel). In addition to cytoskeletal and nuclear
washed cells were incubated with mitotic extract andstaining, ERK antibody stains perinuclear Golgi. Bar 10 mm.
an ATP-regenerating system at 328C for 1 hr. Under
such conditions, Golgi membranes underwent further
depleted extract, which contains activated ERKs, is un- fragmentation into small punctate structures throughout
able to fragment the Golgi. We reason that the target of the cytoplasm as shown in Figure 9A. This fragmentation
MEK must be in the recipient semiintact, salt-washed was also inhibited by treatment of mitotic extract with
cells. If the downstream target for MEK1 is associated PD (data not shown). This finding further confirms that
with the cells, then incubating permeabilized cells with thedownstream target of MEK1remains associated with
excess inactivated ERK should inhibit fragmentation by dispersed Golgi stacks. In addition, this experiment
competing with the bona fide MEK1 target. On the other shows that perinuclear location of Golgi stacks is not
hand, activated ERK should have no effect on the frag- necessary for its fragmentation during mitosis.
mentation process. To test this possibility, the following
experiment was carried out. Permeabilized, salt-washed
cells were preincubated with increasing concentrations Discussion
of inactivated ERK2 (incapable of phosphorylating MBP)
or activated ERK2 (capable of phosphorylating MBP). Fragmentation of Golgi Membranes by Mitotic
Extract in Permeabilized CellsThese cells were incubated with mitotic extract and an
ATP-regeneration system for 1 hr at 328C. Cells were We have established conditions that cause extensive
fragmentation of the Golgi complex by mitotic extractfixed and visualized by fluorescence microscopy using
the Man II antibody. The results are shown in Figure 8A. in permeabilized cells. Visualizationof Golgi membranes
with antibodies to integral membrane proteins revealedIncreasing concentrations of inactivated ERK2 inhibited
Golgi fragmentation while activated ERK2, even at the extensive fragmentation of the complex into punctate
structures that were found dispersed in the cytoplasm.highest concentration, did not. This experiment rein-
forces our findings that MEK1 in the mitotic extract and This change in the organization of Golgi membranes
was easy to score at the light microscopy level andERK in the recipient cell are required for Golgi fragmen-
tation. provided a convenient assay to identify the molecular
MEK1 in Golgi Fragmentation
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MEK Is the Key Kinase in the Golgi
Fragmentation Pathway
It has been shown that endocytic vesicle fusion in vitro
is inhibited by p34cdc2 kinase (Tuomikoski et al., 1989).
Intra-Golgi transport is also inhibited by p34cdc2 and by
another downstream kinase yet to be identified (Stuart
et al., 1993). In addition, it has been shown that p34cdc2
is required for Golgi breakdown using purified Golgi
stacks and cytosol generated from mitotic Hela cells
(Misteli and Warren, 1994). However, these experiments
do not distinguish whether a direct action of p34cdc2 is
necessary or if a downstream kinase once activated by
it can then directly cause Golgi breakdown in the ab-
sence of p34cdc2. We show that p34cdc2 kinase±depleted
mitotic extract has no effect on Golgi fragmentation,
whereas depleting MEK1 is inhibitory. An important clue
about the involvement of MEK1 in Golgi fragmentation
came from use of the MEK1 inhibitor, PD. We found that
treating mitotic extract and not semiintact cells with PD
inhibits Golgi fragmentation. The concentration of PD
required to inhibit MEK1 activation, as measured in vitro,
correlates with inhibition of Golgi fragmentation activity
of PD-treated mitotic extract. While this provides strong
evidence for the requirement of MEK1 activation in Golgi
fragmentation, the most convincing evidence comes
from the finding that mitotic extract depleted of MEK1
is inactive in Golgi fragmentation. Addition of constitu-
tively active MEK1 restores Golgi fragmentation activity
to MEK1-depleted extract.
These results then raise the obvious questionÐwhat
Figure 9. Mitotic Cytosol Fragments Golgi Stacks Regardless of is the downstream target of MEK1 in Golgi fragmenta-
Their Intracellular Location tion? Studies carried out to date indicate that MEK1 is
(A) Distribution of Golgi membranes (stained by Man II antibody) in: highly specific for the downstream components ERK1
semiintact cells (semiintact); semiintact, salt-washed cells incu-
and ERK2. We have shown that mitotic extract con-bated with mitotic extract (semiintact 1 mitotic extract); intact cells
taining inactivated MEK1 (by treatment with PD) con-treated with nocodazole (Noc); and intact cells treated with nocoda-
tains active ERK1 and ERK2 as measured by their abilityzole followed by permeabilization, salt wash, and incubation with
to phosphorylate myelin basic protein. Even more con-mitotic extract (Noc 1 mitotic extract). Fluorescence microscopy
indicates that intact cells show perinuclear Golgi (intact); Golgi is vincing is our finding that depletion of ERK2 from mitotic
dispersed in punctate dots (mitotic extract); discrete stacks are cytosol has no effect on its ability to fragment Golgi
dispersed in the cytoplasm (Noc) and Golgi is again dispersed in membranes. We therefore conclude that mitotic extract
punctate dots (Noc 1 mitotic extract). Bar 10 mm.
does not contain the immediate downstream target for(B) ERK remains associated with Golgi stacks after nocodazole
MEK1 in Golgi fragmentation; instead, the target is lo-treatment. Immunofluorescence of intact cells treated with nocoda-
cated in the semiintact cells employed in the assay.zole, permeabilized, salt washed, and detergent extracted. The left
Results from competition by inactive and activatedpanel shows staining of such cells with anti-Giantin antibody and
the right panel with a broadly reactive anti-ERK antibody. There is ERK2 demonstrate that the downstream target of MEK1
complete colocalization of Golgi staining with both antibodies. Bar is indeed an ERK located in thesemiintact cells. Fluores-
10 mm. cence microscopy reveals that an ERK is tightly associ-
ated with Golgi membranes. It has been shown that ERK
associates with the cytoskeleton (Reszka et al., 1995;
Morishima-Kawashima and Kosik, 1996). This cytoskel-
components involved. Fragmentation was observed etal fraction includes microtubules and a detergent-
only when semiintact cells were washed with a high resistant membrane fraction. We propose that a tightly
ionic strength buffer. High salt wash most likely removed Golgi-associated ERK confers specificity to the effect
inhibitors of Golgi fragmentation by mitotic extract. The of activated MEK1 in Golgi breakdown during mitosis.
major findings that emerge from our study are: (1) p34cdc2 This would serve as an attractive means for phosphory-
kinase, the key kinase for onset of M phase, can be lation and local regulation of Golgi proteins that would
depleted from mitotic extract without affecting Golgi eventually lead to fragmentation of the organelle.
fragmentation activity; (2) MEK1 in the mitotic extract is Interestingly, we find that mitotic extract can fragment
involved in Golgi fragmentation; (3) ERK1 and ERK2, the Golgi stacks when they are perinuclear or dispersed in
downstream targets of MEK1 in the mitotic extract, are the cytoplasm. In addition to strengthening our proposal
not required for Golgi fragmentation, and (4) the down- that the Golgi-associated ERK may be the direct target
stream target of MEK1, however, is an ERK, and we for activated MEK1, these results shed light upon an-
show the presence of a tightly associated ERK on Golgi other important aspect about the fate of Golgi mem-
branes during mitosis. As mentioned in the Introduction,membranes.
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fragmentation has been proposed to ensure partitioning mitosis, and Golgi fragmentation by bg in nondividing
cells may converge on a common Golgi-associated ki-of a single-copy organelle like the Golgi into two daugh-
ter cells. However, this is not a universal process. For nase or its substrate. The identification of MEK1 in Golgi
fragmentation is a significant step toward delineatingexample, in the budding yeast Saccharomyces cerevis-
iae, the Golgi membranes in the new bud are acquired the signaling pathways involved in regulating Golgi
structure during the cell cycle.by migration of intact individual units from the mother
cell (Preuss et al., 1992). Golgi stacks remain intact in
Experimental Proceduresplant cells during cell division (Hirose and Komamine,
1989). We have recently shown that Golgi membranes
Reagents, Antibodies, and Cellsdo not fragment in Drosophila embryos before or after
Pronectin F was obtained from Protein Polymer Tech (San Diego,
cellularization (Stanley et al., 1997). In yeast, plant, and CA). PD 098059 was obtained from New England Biolabs (Beverly,
Drosophila, the Golgi membranes are not perinuclear, MA). Digitonin, calphostin C, nocodazole, and PKI were obtained
unlike in mammalian cells. We have proposed earlier from Calbiochem Novabiochem (San Diego). Thymidine was pur-
chased from Sigma Chemical Co. (St. Louis, MO). g-(32P) ATP wasthat the fate of Golgi membranes is not linked to their
purchased from ICN Pharmaceuticals, Inc (Costa Mesa, CA), proteinintracellular location (Stanley et al., 1997). The fact that
G-Sepharose is from Pharmacia Biotech AB (Uppsala, Sweden), andGolgi membranes in NRK cells fragment by mitotic ex-
centricon 10 is from Amicon (Beverly, MA).
tracts whether perinuclear or not lends further support Rabbit anti-rat mannosidase II (Man II) was a kind gift from Dr.
to this proposal. A speculative possibility is that, while Marilyn Farquhar (University of California, San Diego). Mouse anti-
all cells contain MEK1 and its downstream cytosolic coatomer antibody (CM1A10) was a gift from Dr. James Rothman
(Sloan-Kettering, New York). The anti p34cdc2 antibody was a gifttargets, the Golgi membrane±associated ERK is not
from Dr. R. Baskaran and Dr. Jean Wang (University of California,present in yeast, plants, and Drosophila embryos. This
San Diego), a peptide antibody to p34cdc2 was a gift from Dr. Davidmight explain why Golgi membranes undergo extensive
Morgan (University of California, San Franscisco). The MEK1 anti-
fragmentation in some cells and not in others during body (662) used for immunodepletion, constitutive MEK1 (His-
mitosis. MEKR4F), and inactivated ERK2 were kind gifts from Dr. James
Ferrell (Stanford). The MEK1 antibody used for immunoblotting was
a gift from Dr. Deborah Spector (University of California, San Diego).The Signaling Cascade Involved
The MAPK antibody (ab-1) used for blotting was purchased fromin Golgi Fragmentation
Calbiochem, San Diego. Rhodamine-conjugated goat anti-rabbitMAPK family members are activators and inhibitors of
and fluorescein-conjugated goat anti-mouse were purchased from
cell-cycle machinery (Shibuya et al., 1992; Tamemoto Boehringer-Mannheim Biochemicals (Indianapolis, IN). All tissue
et al., 1992). In the Xenopus oocyte, detailed studies culture cells were grown in complete medium consisting of alpha-
with a Xenopus homolog of ERK2 demonstrate that it MEM (Sigma, St. Louis, MO) with 10% fetal calf serum, 100 U/ml
penicillin, and 100 mg/ml streptomycin at 378C in a 5% CO2 incu-is active and downstream of p34cdc2 during M phase of
bator.the oocyte cell cycle and induces interphase±meta-
phase transition of microtubules (Gotoh et al., 1991).
Preparation of Mitotic and Interphase Extracts
These studies also show that an ERK activator (MEK) The extracts were prepared by the method of Nakagawa (Nakagawa
is one of the intermediates between p34cdc2 and ERK et al., 1989). NRK cells grown attached on 20 cm petri dishes were
(Matsuda et al., 1992). Recent studies in Xenopus ex- incubated with 2 mM thymidine for 10±12 hr to arrest cells in S
phase. The cells were then washed and incubated with 500 ng/tracts and Xenopus tadpole cells (XTC) show that ERK
ml nocodazole overnight at 378C. This treatment arrested cells infunction is required for spindle assembly checkpoints
metaphase. The mitotic cells were rounded up by this treatmentin these systems (Minshull et al., 1994; Min Wang et al.,
and were easily detached from the petri dishes by a ªshake offº
1997). Therefore, the exact role of ERKs depends on the procedure. The cells (95% mitotic index) were washed in PBS fol-
specific activators and the downstream targets. lowed by mitotic extract buffer (MEB) to remove nocodazole. The
Our results show that MEK1 and an ERK are required cells were pelleted and resuspended in twice the packed cell volume
with MEB. The cells were allowed to swell for 10 min on ice and thenfor Golgi fragmentation. Although mitotic extract is en-
homogenized by repeated passages through a 24 gauge needle. Theriched in activated ERKs, it is unable to cause Golgi
homogenized cells were centrifuged in a table top ultracentrifugefragmentation since the ERK is not present in the right
at 48,000 rpm for 45 min using a TLS55 rotor. The resulting high
context as opposed to an ERK anchored to Golgi mem- speed supernatant (with an approximate protein concentration of
branes. We believe that the residence of ERK in physi- 10±12 mg/ml) is termed mitotic extract. The extract was aliquoted,
cally and functionally discrete signaling complexes is frozen in liquid nitrogen, and stored at 2808C. Interphase extract
was prepared from untreated cells by scraping them with a rubberresponsible for the unique specificity of this pathway.
policeman. The buffer andhomogenization conditionswere identicalWhile our studies do not reveal the mechanisms by
to that of mitotic extract. MEB is 15 mM PIPES (pH 7.4), 50 mMwhich MEK1 is activated and how it in turn activates
KCl, 10 mM MgCl2, 20 mM b-mercaptoethanol, 20 mM b-glycero-the Golgi-associated ERK, we favor the idea that MEK1
phosphate, 15 mM EGTA, 0.5 mM spermidine, 0.2 mM spermine, 1
is downstream of p34cdc2 in a kinase cascade.We cannot, mM DTT, 0.1 mM PMSF, 0.2 mg/ml aprotinin, 0.2 mg/ml leupeptin,
however, rule out the possibility that MEK1 could be and 0.2 mg/ml pepstatin.
activated independently of p34cdc2. Recent findings from
Histone H1 Kinase Assayour laboratory suggest that the bg subunit of heterotri-
Histone H1 kinase assay was carried out after the Golgi fragmenta-meric G protein is responsible for Golgi vesiculation in
tion assay, following the protocol described by Dunphy and Newportinterphase cells (Jamora et al., 1997). The target for bg
(1989), except that 32P incorporation was quantitated by a densitom-
in Golgi fragmentation is currently not known. Several eter. In brief, 10 ml from the 50 ml reaction mix used in the Golgi
studies have shown that bg activates the ERK pathway fragmentation assay was mixed on ice with 10 ml of a cocktail con-
in other signaling cascades (Faure et al.,1994). We spec- taining 40 mM HEPES (pH 7.3), 10 mM EGTA, 20 mM MgCl2, 0.2
mg/ml H1, 0.2 mM ATP, 1 mCi g-(32P) ATP, and 20 mM of proteinulate that MEK mediated Golgi fragmentation during
MEK1 in Golgi Fragmentation
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kinase A inhibitor (PKI). After incubation for 10 min at room tempera- Assay of Enzymatic Activity of MEK1
PD treated or untreated mitotic extract was incubated with anti-ture, the reactions were terminated by the addition of Laemmli
buffer. Samples were electrophoresed on a 12% polyacrylamide MEK1 antibody bound to protein G Sepharose. The immunoab-
sorbed MEK1 was incubated with unphosphorylated ERK2 (0.4 mg/gel, the gel was dried, and 32P incorporation was quantitated by
densitometry. We routinely observed a 35 to 40-fold increase of H1 30 ml reaction) for 30 min and 308C. The beads were removed by
centrifugation, and the supernatant containing ERK2 was incubatedkinase activity in mitotic over interphase extract.
with MBP, g-(32P) ATP for 30 min at 308C. The reaction was stopped
by adding Laemmli buffer, analyzed by SDS-PAGE, and quantifiedCell Permeabilization
using a phosphoimager. Activated ERK2 (at the same concentrationNRK cells were grown to 60% confluency on Pronectin F±coated
as inactivated) was used as a positive control in the phosphorylationglass coverslips and incubated with 2 mM thymidine for 8±10 hr at
reaction. The kinase buffer used in this reaction was 30 mM HEPES378C. These cells were washed at room temperature in KHM buffer
(pH 7.2), 10 mM MgCl2, 1 mM DTT, 5 mM benzamidine, 15 mg(25 mM HEPES-KOH [pH 7.2], 125 mM potassium acetate, 2.5 mM
MBP/30 ml, 50 mM ATP, g-(32P) ATP 30 mCi/ 30 ml.magnesium acetate) in 24-well plates and shifted to ice for 2 min
in cold KHM buffer. Cells were then permeabilized with 30 mg/ml
digitonin in KHM buffer and washed with 1 M KCl-KHM, followed Depletion of MEK1 and ERK2 from Mitotic Extract
by KHM. The cells were then inverted on a 50 ml reaction mixture MEK1 was depleted using rabbit antibody 662 coupled to protein
and incubated at 328C for 1 hr. The reaction mix contained KHM, G Sepharose beads overnight. ERK2 was depleted by using rabbit
mitotic extract (final concentration 7 mg/ml), and an ATP-regenera- antibody TR10 conjugated to protein G Sepharose. Mock beads
tion system (final concentration 0.5 mM ATP, 0.3 mM UTP, 10 mM did not contain antibody. Antibody-coupled and mock beads were
creatine phosphate, and 12 IU/ml creatine kinase). incubated with mitotic extract for 90 min with gentle shaking at 48C.
The beads were centrifuged, and supernatant was added to fresh
Immunofluorescence Microscopy beads and incubated for an additional 90 min. The extent of deple-
Cells were fixed and stained as described before (Acharya et al., tion was assessed by SDS-PAGE of mock and depleted extracts
1995a, 1995b). In some cases (Figures 8B and 9B), cells were first followed by immunoblotting. Constitutive MEK1 (his-MEKR4F) was
washed on ice in cytoskeletal stabilization buffer (10 mM PIPES [pH human MEK1 expressed in bacteria and greater than 90% pure. It
7.5], 5 mM EGTA, 15 mM KCl, 2 mM MgCl2, 1 mM DTT, and 0.2 mM was used at a final concentration of 0.5 mg in a 50 ml reaction mix
PMSF) for 2 min followed by extraction for 2 min on ice with 0.0025% from a stock of 0.3 mg/ml.
Triton X-100 in the cytoskeletal stabilization buffer. The cells were
again washed with cytoskeletal stabilization buffer for 1 min and Preincubation of Semiintact, Salt-Washed Cells
then fixed in 4% formaldehyde. The TR2 (anti-ERK) antibody was with Inactive or Activated ERK2
used at 1:100 dilution. Semiintact, salt-washed cells were incubated with different concen-
trations of ERK2 for 10 min at 328C. These cells were then incubated
Incubation of Permeabilized Cells with Protein with mitotic extract and an ATP-regenerating system for 1 hr at
Kinase Inhibitors 328C. Inactivated ERK2 (0.4 mg/ml) was His 6 tagged, bacterially
Mitotic extract was pretreated with specific inhibitors for 10 min at expressed, and purified.
328C. This mixture was then added to semiintact, salt-washed cells
and incubated at 328C for 1 hr. Staurosporine was used at 10 mM Nocodazole Treatment of Intact Cells
from a stock of 1 mM; calphostin C was used at 500 nM from a Intact cells were incubated with 25 mg/ml nocodazole in media
stock of 10 mM. PKI was used at 50 mM final concentration from a containing 25 mM HEPES (pH 7.4) for 2 hr at 378C. These cells were
stock of 500 mM. All stocks were made in DMSO. PD was used at either immediately fixed or permeabilized and treated with mitotic
25, 50, and 75 mM from a stock of 20 mM in DMSO. Mitotic extract extract.
containing a ATP-regeneration system was incubated with different
concentrations of PD for 10 min at 328C. This mixture was then Acknowledgments
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